Mechanisms of endothelial quiescence: towards new targets in Rendu-Osler disease – ENQUIRE
Endothelial cells form the inner layer of blood vessels. These cells play a central role in the formation of new blood vessels in a process called angiogenesis. At adult stage, endothelial cells become quiescent while still controlling important biological processes different from one organ to another. Dysfunction of adult endothelium is a factor in the physiopathology of numerous vascular diseases. My project aims to better understand regulators that keep pulmonary and hepatic endothelia functional, with a particular focus on the ALK1 signaling pathway. ALK1 is a receptor exclusively expressed by endothelial cells and ALK1 mutations are responsible of the Rendu-Osler disease. By combining in vivo and in vitro models and state-of-the-art technologies, I aim to develop innovative therapies to cure the Rendu-Osler disease.
Project coordination
Nicolas Ricard (Biologie et biotechnologies pour la santé)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partnership
Biologie et biotechnologies pour la santé
Help of the ANR 287,702 euros
Beginning and duration of the scientific project:
September 2021
- 48 Months